1. Effect of dupilumab on atopic manifestations in patients treated for atopic dermatitis in real‐life practice. (1st June 2019) Authors: Tauber, M.; Apoil, P.A.; Richet, C.; Laurent, J.; De Bonnecaze, G.; Mouchon, E.; Cassagne, M.; Marguery, M.C.; Hegazy, S.; Konstantinou, M.P.; Severino, M.; Uthurriague, C.; Giordano‐Labadie, F.; Didier, A.; Paul, C. Journal: British journal of dermatology Issue: Volume 180:Number 6(2019) Page Start: 1551 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effect of dupilumab on atopic manifestations in patients treated for atopic dermatitis in real‐life practice. (27th March 2019) Authors: Tauber, M.; Apoil, P.A.; Richet, C.; Laurent, J.; De Bonnecaze, G.; Mouchon, E.; Cassagne, M.; Marguery, M.C.; Hegazy, S.; Konstantinou, M.P.; Severino, M.; Uthurriague, C.; Giordano‐Labadie, F.; Didier, A.; Paul, C. Journal: British journal of dermatology Issue: Volume 180:Number 6(2019) Page Start: 1551 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy of ustekinumab in palmoplantar pustulosis. (8th January 2018) Authors: Hegazy, S.; konstantinou, M.P.; Bulai Livideanu, C.; Tauber, M.; Uthurriague, C.; Paul, C. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 32:Number 5(2018) Page Start: e204 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Langerhans cell histiocytosis associated with chronic myelomonocytic leukaemia both harbouring the same BRAF V600E mutation: efficacy of vemurafenib. (1st September 2020) Authors: Konstantinou, M.P.; Lucas, P.; Uthurriague, C.; Severino‐Freire, M.; Spenatto, N.; Gaudin, C.; Lamant, L.; Tournier, E.; Bulai‐Livideanu, C.; Meyer, N.; Paul, C. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 35:Number 2(2021) Page Start: e120 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Vemurafenib significantly decreases glomerular filtration rate. (23rd November 2013) Authors: Uthurriague, C.; Thellier, S.; Ribes, D.; Rostaing, L.; Paul, C.; Meyer, N. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 28:Number 7(2014:Jul.) Page Start: 978 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗